Adaptive Biotechnologies (ADPT) Net Cash Flow (QoQ) (2018 - 2026)
Adaptive Biotechnologies (ADPT) Net Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.04% |
| Dec 31, 2025 | 30.58% |
| Sep 30, 2025 | 258.42% |
| Jun 30, 2025 | -394.25% |
| Mar 31, 2025 | -73.96% |
| Dec 31, 2024 | 144.88% |
| Sep 30, 2024 | -90.75% |
| Jun 30, 2024 | -283.81% |
| Mar 31, 2024 | 126.23% |
| Dec 31, 2023 | -15.14% |
| Sep 30, 2023 | -234.74% |
| Jun 30, 2023 | 238.65% |
| Mar 31, 2023 | 103.53% |
| Dec 31, 2022 | -190.38% |
| Sep 30, 2022 | 468.20% |
| Jun 30, 2022 | -59.60% |
| Mar 31, 2022 | -244.12% |
| Dec 31, 2021 | 126.97% |
| Sep 30, 2021 | -684.97% |
| Jun 30, 2021 | -78.96% |